34
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Role of TGF-β1 in Platelet-mediated Cardioprotection During Ischemia-reperfusion in Isolated Rat Hearts

, , &
Pages 179-190 | Received 07 May 1998, Accepted 04 Nov 1998, Published online: 11 Jul 2009

References

  • Addonizio V. P., Wetstein L., Fisher C. A., Feldman P., Harken A. H. Platelet-mediated cardiac ischemia. J. Surg. Res. 1982; 33: 402–408
  • Aherne T., Price D. C., Yee E. S., Hsieh W. R., Ebert P. A. Prevention of ischemia-induced myocardial platelet deposition by exogenous prostacyclin. J. Thorac. Cardiovase. Surg. 1986; 92: 99–104
  • Barr P. J. Mammalian subtilisins: the long-sought dibasic-processing endoproteases. Cell 1991; 66: 1–3
  • Casscells W., Bazobcrry F., Speir E., Thompson N. L., Flanders K., Kondaiah P., Ferraris V. J., Epstein S. E., Sporn M. B. Transforming growth factor-beta 1 in normal heart and in myocardial infarction. Ann. N. Y. Acad. Sci. 1990; 593: 148–160
  • Claesson-Welsh I. Mechanism of action of platelet-derived growth factor. Int. J. Biochem. Cell Biol. 1996; 28: 373–385
  • Conti C. R., Mehta J. L. Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm and altered arachidonic acid metabolism. Circulation 1987; 75(suppl. V)V84–95
  • Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
  • Fazio S., Sabatim D., Capaldo B., Vigorito V., Giordano A., Guida R., Pardo F., Biondi B., Sacca L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 1996; 334: 809–814
  • Feinberg H., Rosenbaum D. S., Levitsky S., Silverman N. A., Kohler J., LeBreton G. Platelet deposition after surgically induced myocardial ischemia. J. Thorac. Cardiovase. Surg. 1982; 84: 815–822
  • Folts J. D., Crowell E. B.J, Rowe G. G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365–370
  • Freese A., Finklestein S. P., Difiglia M. Basic fibroblast growth factor protects striatal neurons In vitro from NMDA-receptor mediated excitotoxicity. Brain Rex. 1992; 575: 351–355
  • Golino P., Maroko P., Carcw T. E. Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation 1987; 76: 173–180
  • Grainger D. J., Kemp P. R., Metcalfe J. C., Liu A. C., Lawn N. R., Williams N. R., Grace A. A., Schofield P. M., Heffner J. E. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Medicine 1995; 1: 74–79
  • Heffner J. E., Katz S. A., Halushka P. V., Cook J. A. Human platelets attenuate oxidant injury in isolated rabbit lungs. J. Appl. Physiol. 1988; 65: 1258–1266
  • Herskowitz A., Choi S., Ansari A. A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am. J. Pathol. 1995; 146: 419–428
  • Jakowlew S. B., Dillard P. J., Sporn M. B., Roberts A. B. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. Mol. Endocrinol. 1988; 2: 1186–1195
  • Lefer A. M., Ma X-L., Weyrich A. S., Scalia R. Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. USA 1993; 90: 1018–1022
  • Lefer A. M., Tsao P., Aoki N., Palladino M. A., Jr. Mediation of cardioprotection by transforming growth factor-β. Science 1990; 249: 61–64
  • Maury C. P., Teppo A. M. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J. Intern. Med. 1989; 225: 333–336
  • Mawatari M., Kohno K., Mizoguchi H., Matsuda T., Asoh K., Van Damme J., Welgus H. G., Kuwano M. Effects of tumour necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J. Immunol. 1989; 143: 1619–1627
  • McGarrity S. G., Stephenson A. H., Hyers T. M., Webster R. O. Inhibition of neutrophil superoxide anion generation by platelet products: role of adenine nucleotides. J. Leuk. Biol. 1988; 44: 411–421
  • Mehta J. L., Nichols W. W., Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J. Am. Coll. Cardiol. 1988; 11: 1309–13016
  • Moses H. L., Branum E. L., Proper J. A., Robinson R. A. Transforming growth factor production by chemically transformed cells. Cancer Res. 1981; 41: 2842
  • Mullane K. M., McGriff J. C. Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. J. Cardiovasc. Pharmacol. 1985; 7: 733–738
  • Munakata S., Hendricks J. B. Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J. Histochem. Cytochem. 1993; 41: 1241–1246
  • Murphy-Ullrich J. E., Schultz-Cherry S., Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol. Cell. Biol. 1992; 3: 181–188
  • Neely T. R., Rovetto M. J. Techniques for perfusing isolated rat hearts. Methods Enzymol. 1975; 39: 43–60
  • Padua R. R., Sethi R., Dhalla N. S., Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol. Cell Biochem. 1995; 143: 129–135
  • Paty P. S.K., Sherman P. F., Shepard J. M., Malik A. B., Kaplan J. E. Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am. J. Physiol. 1992; 262: H771–777
  • Ramos-Martinez J. I., Launay J. M., Dreux C. A sensitive fluorometric microassay for the determination of glutathione peroxidase activity. Application to human blood platelets. Anal. Biochem. 1979; 98: 154–159
  • Ranges G. E., Figari I. S., Espevik T., Palladino M. A., Jr. Inhibition of cytotoxic Tcell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 1987; 166: 991–998
  • Roberts A. B., Sporn M. B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993; 8: 1–9
  • Roberts A. B., Flanders K. C., Kondaiah P., Thompson N. L., Van Obberghen S. E., Wakefield L., Rossi P., de Crombrugghe B., Heine U., Sporn M. B. Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog. Horn. Res. 1988; 44: 157–197
  • Roberts A. B., Roche N. S., Winokur T. S., Burmester J. K., Sporn M. B. Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. J. Clin. Invest. 1992; 90: 2056–2062
  • Sacks T., Moldow C. F., Craddock P. R., Bowers T. K., Jacob H. S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest. 1978; 61: 1161–1167
  • Schror K., Braun M. Platelets as a source of vasoactive mediators. Stroke 1990; 21(suppl. IV)IV-32–IV-35
  • Schultz-Cherry S., Lawler J., Murphy-Ullrich J. E. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J. Biol. Chem. 1994; 269: 26783–26788
  • Stein B., Fuster V. Clinical pharmacology of platelet inhibitors. Thrombosis in Cardiovascular Disorders, V. Fuster, M. Verstraete. WB Saunders, Philadelphia, PA 1992; 99–120
  • Thompson N. L., Bazoberry F., Speir E. H., Casscells W., Ferrans V. J., Flanders K. C., Kondaiah P., Geiser A. G., Sporn M. B. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1988; 1: 91–99
  • Van den E., Raaij A. J.M., Koornneef I., van Zoelen E. J.J. A new method for high yield purification of type beta transforming growth factor from human platelets. Biochem. Biophys. Res. Commun. 1988; 157: 16–23
  • Waltenberger J. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases. Circulation 1997; 96: 4081–4094
  • Yang B. C., Mehta J. L. Platelet-derived adenosine contributes to the cardioprotective effects of platelets against ischemia-reperfusion injury in isolated rat heart. J. Cardiovasc. Pharmacol. 1994; 24: 779–785
  • Yang B. C., Mehta A., Mehta J. L. Cardioprotective effects of platelets against ischemia-reperfusion injury are related in part to platelet glutathione redox cycle. Cardiovasc. Res. 1994; 28: 1586–1593
  • Yang B. C., Virmani R., Nichols W. W., Mehta J. L. Platelets protect against myocardial dysfunction and injury induced by ischemia and reperfusion in isolated rat hearts. Circ. Res. 1993; 72: 1181–1190
  • Yee E. S., Price D. C., Aherne T., Ebert P. A. Intracoronary platelet aggregation: pattern of deposition after ischemia, cardioplegia, and reperfusion. J. Surg. Res. 1986; 40: 499–503
  • Zamora C. A., Baron D., Heffner J. E. Washed human platelets prevent ischemia-reperfusion edema in isolated rabbit lungs. J. Appl. Physiol. 1991; 70: 1075–1084

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.